Advanced search
News (63)
Insiders
Mr. Mathieu O. Floreani is a Chairman-Management Board & CEO at Synlab AG, a Co-Managing Director at LS Medizin Service GmbH, a Group Chief Executive Officer at SYNLAB International GmbH and a Co-Managing Director at Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH. He is on the Board of Directors at Synlab Diagnósticos Globales SA, ALcontrol Group Ltd., Labco UK Group Ltd. and SYNLAB Ltd. Mr. Floreani was previously employed as a President, Chief Executive Officer & Director by DHL Global Forwarding North America and a Managing Director by SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH.
Mr. Patrick Floreani, CFA MBA, is a Managing Director & Chief Investment Officer at WealthBridge Investment Counsel, Inc. He is also primarily responsible for the equity portion of client portfolios.
Mr. Floreani was previously employed as a Chief Investment Officer by Société Générale (Canada) and a Partner & Portfolio Manager by Canadian Wealth Management Corp.
He is a graduate of the University of Alberta.
After graduating with a Bachelor of Science degree, He then obtained his Master of Business Administration degree, also from the University of Alberta.
He obtained his Chartered Financial Analyst charter in 1998.
Martin E.
Floreani is currently the President & Chief Executive Officer at French Transit LLC since 2017.
Previously, he worked as the Regional Marketing Manager at Merck & Co., Inc., Vice President-Global Strategy at Stiefel Laboratories, Inc., VP-International Sales & Market Development at Advanced Bio-Technologies, Inc., and Chief Marketing Officer & EVP-International at Enaltus LLC.
Mr. Floreani completed his undergraduate and MBA degrees from Miami University.
No results for this search
- Stock Market
- Advanced search
- Mathieu Floreani